Free Trial

David Turkaly Analyst Performance

Research Analyst at JMP Securities

David Turkaly is a stock analyst at JMP Securities focused in the medical sector, covering 22 publicly traded companies. Over the past year, David Turkaly has issued 15 stock ratings, including buy and hold recommendations. While full access to David Turkaly's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights David Turkaly's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
43 Last 10 Years
Buy Recommendations
83.72% 36 Buy Ratings
Companies Covered
22 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy83.7%36 ratings
Hold16.3%7 ratings
Sell0.0%0 ratings

Out of 43 total stock ratings issued by David Turkaly at JMP Securities, the majority (83.7%) have been Buy recommendations, followed by 16.3% Hold.

Exchange Coverage

ExchangePercentageCount
NYSE
54.5% of companies on NYSE
12 companies
NASDAQ
45.5% of companies on NASDAQ
10 companies

David Turkaly, an analyst at JMP Securities, currently covers 22 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
17 companies
77.3%
Finance
3 companies
13.6%
Computer and Technology
2 companies
9.1%

David Turkaly of JMP Securities specializes in stock coverage within the Medical sector, with additional focus on Finance and Computer and Technology companies.

Coverage Industries

IndustryPercentage
MED INSTRUMENTS
8 companies
36.4%
MED PRODUCTS
4 companies
18.2%
SURGICAL & MEDICAL INSTRUMENTS
2 companies
9.1%
REIT - MTGE TRUST
2 companies
9.1%
MEDICAL INFO SYS
1 company
4.5%
SECURITY
1 company
4.5%
MED - BIOMED/GENE
1 company
4.5%
COMP - SOFTWARE
1 company
4.5%
REIT - EQTY TRUST - OTHER
1 company
4.5%
SURGICAL APPLIANCES & SUPPLIES
1 company
4.5%

David Turkaly's Ratings History at JMP Securities

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
8/8/2025Set Price Target$19.20$35.00Market Outperform
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
8/7/2025Lower Price Target$53.79$73.00Market Outperform
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
6/6/2025Reiterated Rating$11.02Market Perform
Globus Medical, Inc. stock logo
GMED
Globus Medical
5/27/2025Reiterated Rating$59.00Market Perform
Haemonetics Corporation stock logo
HAE
Haemonetics
5/20/2025Reiterated Rating$69.39$100.00Market Outperform
STERIS plc stock logo
STE
STERIS
5/16/2025Boost Price Target$250.35$280.00Market Outperform
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
5/9/2025Lower Price Target$12.63$25.00Market Outperform
Enovis Corporation stock logo
ENOV
Enovis
5/9/2025Lower Price Target$32.52$55.00Market Outperform
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
5/7/2025Lower Price Target$94.18$125.00Market Outperform
CrowdStrike stock logo
CRWD
CrowdStrike
5/5/2025Boost Price Target$449.96$500.00Market Outperform
Stryker Corporation stock logo
SYK
Stryker
5/5/2025Reiterated Rating$376.27Market Perform
STERIS plc stock logo
STE
STERIS
4/10/2025Reiterated Rating$219.12$265.00Market Outperform
Stryker Corporation stock logo
SYK
Stryker
2/18/2025Reiterated Rating$382.74Market Perform
Haemonetics Corporation stock logo
HAE
Haemonetics
2/7/2025Lower Price Target$60.90$100.00Market Outperform
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
1/14/2025Reiterated Rating$94.65$112.00Market Outperform